Preview

FARMAKOEKONOMIKA. Modern Pharmacoeconomics and Pharmacoepidemiology

Advanced search

Search


Order results by:     
 
Issue Title
 
Vol 17, No 1 (2024) Pharmacoeconomic evaluation of first-line combination therapy with immunotherapy drugs and platinum-containing chemotherapy in adult patients with metastatic non-squamous non-small cell lung cancer Abstract  similar documents
S. К. Zyryanov, I. N. Dyakov
"... пациента в течение 2 лет на 28 165,00 руб. (–0,4%). В рамках анализа влияния на бюджет показано, что ..."
 
Vol 17, No 4 (2024) Economic effectiveness of fixed-dose combination of alogliptin and pioglitazone in diabetes mellitus treatment Abstract  similar documents
S. К. Zyryanov, I. N. Dyakov
"... минимизации затрат, анализ влияния на бюджет) с учетом эффективности сравниваемых режимов терапии. Данные о ..."
 
Vol 16, No 3 (2023) Updated pharmacoeconomic analysis of atesolizumab efficiency compared with other PD-1 inhibitors in patients with advanced non-small cell lung cancer after chemotherapy Abstract  similar documents
S. K. Zyryanov, I. N. Dyakov
"... анализ минимизации затрат, оценено влияние на бюджет системы здравоохранения при лечении всех пациентов с ..."
 
Vol 15, No 2 (2022) Pharmacoeconomic analysis of the use of a fixed combination of tiotropium bromide and olodaterol as maintenance therapy in patients with chronic obstructive pulmonary disease in the Russian Federation Abstract  similar documents
S. К. Zyryanov, I. N. Dyakov
"... антихолинергическими препаратами (ДДАХ) при ее недостаточной эффективности. Материал и методы. Проведен анализ влияния ..."
 
Vol 17, No 2 (2024) Cost-effectiveness analysis of acalabrutinib in treatment of patients with relapsed/refractory form of mantle cell lymphoma who previously received at least one line of therapy Abstract  similar documents
S. K. Zyryanov, I. N. Dyakov
"... лекарственные препараты) на горизонте 3 лет. Результаты анализа минимизации затрат проверяли на устойчивость в ..."
 
Vol 15, No 3 (2022) The role of real world data and real world evidence in health technology assessment Abstract  similar documents
E. A. Novoderezhkina, S. К. Zyryanov
"... . real world data, RWD), а также доказательств, получаемых путем анализа данных РКП (англ. real world ..."
 
Vol 14, No 3 (2021) Pharmacoeconomic analysis of the application of strong opioids for the treatment of chronic pain syndrome in patients with pancreatic cancer Abstract  similar documents
O. P. Bobrova, S. K. Zyryanov, N. A. Shnayder, M. M. Petrova
"... Цель: оценить клинико-экономическую целесообразность опиоидной терапии на основе анализа ее ..."
 
1 - 7 of 7 Items

Search tips:

  • Search terms are case-insensitive
  • Common words are ignored
  • By default articles containing any term in the query are returned (i.e., OR is implied)
  • Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
  • Combine multiple words with AND to find articles containing all terms; e.g., education AND research
  • Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
  • Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
  • Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)